Table 3.
HBOT, HBAT and HBT in children with CP, 8 groups, n = 316.
| References | Treatments | n | Age (months) | Treatment duration (months) | GMFM initial (%) | GMFM final (%) | Gain GMFM | ENE | GMFMER | |
|---|---|---|---|---|---|---|---|---|---|---|
| Collet et al. 2001 | (62) | HBOT-1.75ATA | 57 | 86.4 | 2.0 | 57.3 | 60.2 | 2.9 | 0.1 | 36.3 |
| Mukherjee et al. 2014 | (43) | HBOT-1.75ATA | 58 | 51.6 | 6.0 | 32.5 | 42.1 | 9.6 | 0.5 | 20.9 |
| Mukherjee et al. 2014 | (43) | HBOT-1.5ATA | 32 | 51.6 | 6.0 | 34.3 | 42.5 | 8.2 | 0.5 | 16.4 |
| Lacey, Stolfi, et Pilati 2012 | (11) | HBOT-1.5ATA | 25 | 75.6 | 2.0 | 39.5 | 40.7 | 1.2 | 0.1 | 20.0 |
| Montgomery et al. 1999 | (63) | HBOT-1.75ATA | 25 | 67.2 | 1.0 | 56.9 | 61.6 | 4.7 | 0.1 | 47.0 |
| Mean | 66.5 | 3.4 | 44.1 | 49.4 | 5.3 | 0.2 | 28.1 | |||
| SD | 15.2 | 2.4 | 12.1 | 10.5 | 3.5 | 0.2 | 13.0 | |||
| Collet et al. 2001 | (62) | HBAT-1.3ATA | 54 | 86.4 | 2.0 | 66.3 | 69.3 | 3.0 | 0.1 | 25.0 |
| Mukherjee et al. 2014 | (43) | HBAT-1.3ATA | 40 | 58.8 | 6.0 | 29.6 | 38.6 | 9.0 | 0.3 | 34.6 |
| Mean | 72.6 | 4.0 | 48.0 | 54.0 | 6.0 | 0.2 | 29.8 | |||
| SD | 19.5 | 2.8 | 26.0 | 21.7 | 4.2 | 0.1 | 6.8 | |||
| Lacey, Stolfi, et Pilati 2012 | (11) | HBT-1.5ATA + 14%O2 | 25 | 62.5 | 2.0 | 40.7 | 41.8 | 1.1 | 0.1 | 8.5 |
ENE, expected natural evolution; GMFM, gross motor function measure; GMFMER, gross motor function measure evolution ratio; HBAT, hyperbaric air treatment; HBOT, hyperbaric oxygen treatment; HBT, hyperbaric treatment.